Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
Loukia Yiangou, Richard P. Davis, Christine L. Mummery
Stem Cell Reports (2020) Vol. 16, Iss. 3, pp. 385-397
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

COVID-19 and Cardiovascular Disease
Mina K. Chung, David A. Zidar, Michael R. Bristow, et al.
Circulation Research (2021) Vol. 128, Iss. 8, pp. 1214-1236
Open Access | Times Cited: 346
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 69
The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research
Lars Muhl, Liqun He, Ying Sun, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 5, pp. 1089-1104
Open Access | Times Cited: 62
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2
Liuliu Yang, Benjamin E. Nilsson-Payant, Yuling Han, et al.
Stem Cell Reports (2021) Vol. 16, Iss. 9, pp. 2274-2288
Open Access | Times Cited: 45
Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models
Elisa Mohr, Thomas Thum, Christian Bär
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1778-1791
Open Access | Times Cited: 27
Harnessing three-dimensional (3D) cell culture models for pulmonary infections: State of the art and future directions
Disha D. Shah, Neha R. Raghani, Mehul R. Chorawala, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 11, pp. 2861-2880
Open Access | Times Cited: 18
Human Pluripotent Stem Cell–Derived Cardiomyocytes for COVID-19 Cardiovascular Complications: A Versatile In Vitro Model for Studying Acute and Chronic SARS-CoV-2 Infection
Carmen Lopez-Munoz, Noah Jackson Bowers, Silvia Marchianò
Current Treatment Options in Cardiovascular Medicine (2025) Vol. 27, Iss. 1
Closed Access
Step-by-step fabrication of heart-on-chip systems as models for cardiac disease modeling and drug screening
Sara Deir, Yasaman Mozhdehbakhsh Mofrad, Shohreh Mashayekhan, et al.
Talanta (2023) Vol. 266, pp. 124901-124901
Closed Access | Times Cited: 11
COVID-19’s immuno-pathology and cardiovascular diseases
Entezar Mehrabi Nasab, Hassan Aghajani, Reza Hassanzadeh Makoei, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 2, pp. 71-80
Open Access | Times Cited: 10
Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery
Juan Huang, Qi Feng, Li Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 20
3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery
Guadalupe Tonantzin de Dios-Figueroa, Janette del Rocío Aguilera-Márquez, Tanya A. Camacho-Villegas, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 602-602
Open Access | Times Cited: 20
A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-based therapies with a Focus on the Registered Clinical Trials
Negin Mahmoudi, Negar Mohammadi Ganjaroudi, Alireza Soltani Khaboushan, et al.
Qeios (2024)
Open Access | Times Cited: 2
ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis
Anastasia V. Poznyak, Evgeny E. Bezsonov, Ali H. Eid, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4691-4691
Open Access | Times Cited: 18
Microphysiological stem cell models of the human heart
Ulgu Arslan, Alessia Moruzzi, Joanna Nowacka‐Woszuk, et al.
Materials Today Bio (2022) Vol. 14, pp. 100259-100259
Open Access | Times Cited: 11
Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection
Thomas Williams, Maria Colzani, Robyn Macrae, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 14
Blockchain Assisted Disease Identification of COVID-19 Patients with the Help of IDA-DNN Classifier
C. B. Sivaparthipan, BalaAnand Muthu, G. Fathima, et al.
Wireless Personal Communications (2022) Vol. 126, Iss. 3, pp. 2597-2620
Open Access | Times Cited: 10
COVID-19 pathogenesis
Asiya Kamber Zaidi, Rohan Bir Singh, Syed A. A. Rizvi, et al.
Progress in molecular biology and translational science (2024)
Closed Access | Times Cited: 1
Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling
Mária Csöbönyeiová, Martin Klein, Marcela Kuniaková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3459-3459
Open Access | Times Cited: 3
Recent Advances of COVID-19 Modeling Based on Regenerative Medicine
Bagher Larijani, Najmeh Foroughi-Heravani, Mina Abedi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 8
2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases
Feng Bai, Jun Pu, Wenliang Che, et al.
Cardiology Plus (2023)
Open Access | Times Cited: 2
Inhibition of SARS-CoV-2 infection in human cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoskeleton architecture and contractility
José Alexandre Salerno, Thayana Torquato, Jairo R. Temerozo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 6
Spike-based adenovirus vectored COVID-19 vaccine does not aggravate heart damage after ischemic injury in mice
Shanshan Gu, Zhongyan Chen, Xiangfu Meng, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 4
The athlete after COVID-19 infection: what the scientific evidence? What to do? A position statement
Silvia Castelletti, Salvatore Francesco Gervasi, Enrico BALLARDINI, et al.
Panminerva Medica (2022) Vol. 66, Iss. 1
Open Access | Times Cited: 4
Application of the Pluripotent Stem Cells and Genomics in Cardiovascular Research—What We Have Learnt and Not Learnt until Now
Michael Simeon, Seema Dangwal, Agapios Sachinidis, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3112-3112
Open Access | Times Cited: 5
A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-based therapies with a Focus on the Registered Clinical Trials
Negin Mahmoudi, Negar Mohammadi Ganjaroudi, Alireza Soltani Khaboushan, et al.
Qeios (2024)
Open Access
Page 1 - Next Page

Scroll to top